Author: Dr. David Lowemann

Skeletal muscle health amid growing use of weight loss medications

A recent article highlights the critical importance of skeletal muscle mass in the context of medically induced weight loss, particularly with the widespread use of GLP-1 receptor agonists. These medications, celebrated for their effectiveness in treating obesity, have raised concerns regarding the potential for substantial muscle loss as part of the weight loss process. Read […]

Published on October 25, 2024

Dr. Crandall: Chelation Therapy Treats Heart Disease

Chelation therapy, long used to treat heavy metal poisoning, is now gaining attention as an effective therapy for certain heart conditions. The use of chelation dates back to World War II when it was used as an antidote against arsenic-containing gas exposure and then later… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, […]

Published on October 25, 2024

E. Coli Outbreak Linked to McDonald’s Expands

A deadly outbreak of E. coli poisoning tied to McDonald’s Quarter Pounders has expanded, with at least 75 people sick in 13 states, federal health officials said Friday. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads […]

Published on October 25, 2024